Credit Suisse’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-56,974
| Closed | -$7.79M | – | 4144 |
|
|
2018
Q2 | $7.79M | Buy |
56,974
+23,902
| +72% | +$2.17M | 0.01% | 1400 |
|
|
2018
Q1 | $2.6M | Buy |
33,072
+12,678
| +62% | +$935K | ﹤0.01% | 2211 |
|
|
2017
Q4 | $1.39M | Buy |
20,394
+255
| +1% | +$13.2K | ﹤0.01% | 2749 |
|
|
2017
Q3 | $809K | Buy |
20,139
+3,199
| +19% | +$123K | ﹤0.01% | 3249 |
|
|
2017
Q2 | $674K | Buy |
16,940
+4,293
| +34% | +$157K | ﹤0.01% | 2944 |
|
|
2017
Q1 | $408K | Sell |
12,647
-4,514
| -26% | -$113K | ﹤0.01% | 3398 |
|
|
2016
Q4 | $304K | Buy |
17,161
+4,808
| +39% | +$104K | ﹤0.01% | 3657 |
|
|
2016
Q3 | $288K | Sell |
12,353
-9,140
| -43% | -$207K | ﹤0.01% | 3671 |
|
|
2016
Q2 | $401K | Buy |
+21,493
| New | +$388K | ﹤0.01% | 3549 |
|
|
2015
Q3 | – | Sell |
-59,493
| Closed | -$2.01M | – | 4616 |
|
|
2015
Q2 | $2.01M | Buy |
59,493
+30,801
| +107% | +$1.24M | ﹤0.01% | 2557 |
|
|
2015
Q1 | $1.38M | Sell |
28,692
-11,006
| -28% | -$499K | ﹤0.01% | 2719 |
|
|
2014
Q4 | $882K | Buy |
39,698
+16,756
| +73% | +$387K | ﹤0.01% | 3247 |
|
|
2014
Q3 | $436K | Buy |
+22,942
| New | +$547K | ﹤0.01% | 3734 |
|
|
2014
Q2 | – | Sell |
-22,105
| Closed | -$715K | – | 4895 |
|
|
2014
Q1 | $715K | Buy |
22,105
+12,552
| +131% | +$408K | ﹤0.01% | 3428 |
|
|
2013
Q4 | $227K | Buy |
+9,553
| New | +$267K | ﹤0.01% | 4267 |
|
Credit Suisse's FMI Position: Q3 2018 in Review
Credit Suisse sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 56,974 shares — an estimated $7.79M sold.
Credit Suisse first reported a position in FMI in Q4 2013 and held it in 15 quarters. The position peaked at $7.79M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Credit Suisse reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Credit Suisse sold 56,974 Foundation Medicine, Inc. shares in Q3 2018, an estimated $7.79M.
- Credit Suisse first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 15 quarters.
- Credit Suisse's Foundation Medicine, Inc. position peaked at $7.79M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Credit Suisse's 13F filing for Q3 2018, filed 13 Nov 2018.